Finox
| Finox AG | |
|---|---|
| legal form | Corporation |
| ISIN | CH0363058294 |
| founding | 2007 |
| Seat |
Burgdorf BE , Switzerland Kirchberg BE ( administrative headquarters )
 |
| management | Gavin Jelic-Masterton ( CEO ) |
| Branch | Biopharmaceuticals ( biosimilars ) |
| Website | www.finoxbiotech.com |
The Finox AG is a worldwide Finox Biotech occurring in the market Swiss biotechnology company that segment of the biosimilar operates. The company's headquarters are in Burgdorf BE , the Finox Biotech HQ is in Kirchberg BE . The company, which was founded in 2007, like all other companies in the Finox Group , has been a wholly-owned subsidiary of the Hungarian pharmaceutical company Gedeon Richter since June 2016 .
history
Finox Biotech was founded in 2007 by Willy Michel , who was indirectly the main shareholder through the holding company BV Holding, which he controls, until June 2016. In June 2016, the Hungarian pharmaceutical company Gedeon Richter acquired one hundred percent of the Swiss Finox Holding AG along with all of its investments (Finox AG and all foreign companies).
Field of activity
Finox Biotech is dedicated to fertility treatment.
The first Finox Biotech preparation approved by the European Commission at the instigation of the European Medicines Agency (EMA) is Bemfola . Bemfola contains the biotechnologically produced active ingredient follitropin alfa, also known as follicle-stimulating hormone (FSH) . This hormone is used as a drug in the treatment of involuntary childlessness due to infertility to stimulate the female egg cells . As a biosimilar (successor product of a biopharmaceutical whose patent protection has expired), Bemfola corresponds to a biological medicinal product that has already been approved in the EU. The reference medicine for Bemfola is GONAL-f by Merk Serono .
Web links
Individual evidence
- ^ Company history , company website, accessed July 14, 2015.
- ↑ Management . Finox website, accessed June 10, 2018.
- ↑ Richter announces the acquisition of Finox Holding for a consideration of CHF 190 million . Gedeon Richter Plc., Press release, June 30, 2016, accessed June 10, 2018.
- ↑ Stefan Schnyder: Willy Michel is selling his start-up . In: Berner Zeitung , July 1, 2016, accessed on June 10, 2018.
- ↑ Summary of the European public assessment report (EPAR) for Bemfola , EPAR, accessed on July 14, 2015.
- ↑ Summary of the EPAR for the public , EPAR (German), accessed on July 14, 2015.